Mead Johnson Nutrition Company MJN unveils its next round of earnings this Thursday, July 28, 2011. Here's Benzinga's essential guide to Mead Johnson Nutrition Company's second quarter earnings report.
Earnings and Revenue:
Wall Street expects a EPS of 69 cents per share and revenues of $878.7 million. Wall Street will be looking to see how this quarter's numbers compare to the year-ago quarter's positive EPS of 64 cents per share on revenues of $764.2 million. We'll have to wait for Thursday to see if Mead Johnson Nutrition Company has accomplished the estimated 7.8% rise in EPS and 15% increase in revenues on a year-over-year basis.Here's how the company's reported EPS has stacked up against analyst estimates in the past:
Quarter | Q1 | Q4 | Q3 | Q2 |
EPS Estimate | $0.71 | $0.56 | $0.58 | $0.62 |
EPS Actual | $0.76 | $0.57 | $0.57 | $0.64 |
Stock Performance:
As of July 22, 2011, Mead Johnson Nutrition Company's current share price was $69.08. Since January 1st, shares of Mead Johnson Nutrition Company have given investors a return of 11.9%.Average Stock Rating:
The average rating by analysts for Mead Johnson Nutrition Company is a Hold. The strength of this rating has declined slightly over the past three months.Competitors:
Looking for a sympathy stock to trade or interested in the performance of other companies in the same sector? Take a look at some of Mead Johnson Nutrition Company's peers.- Dean Foods Company (DF): Hold with a $0.14 recent quarter EPS
The medical products company's industry has seen price/earnings growth of 1.5% during the current fiscal year.
Finally, a description of the company's main areas of operation: Mead Johnson Nutrition Company provides of pediatric nutrition and related products.
Take Action:
That's your advanced look at Mead Johnson Nutrition Company's upcoming earnings numbers -- be ready to take quick action if the company's report contains any surprises. Also, check back in with us after the announcement for a full recap and what-to-do-next guide.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.